Advertisement
Imaging
Subscribe to Imaging
View Sample

FREE Email Newsletter

ULURU Inc. Provides Altrazeal® Clinical Update

November 10, 2010 8:36 am | by Bio-Medicine.Org | News | Comments

ADDISON, Texas, Nov. 10, 2010 /- ULURU Inc. (NYSE Amex: ULU ) today provided a clinical update and summary of recent participation at major wound care conferences. During the past 45 days Altrazeal® has been presented at three major wound care conferences Symposium of Advanced Wound...

Medisafe 1 Technologies to Exhibit at World's Largest Medical Conference

November 10, 2010 8:35 am | by Bio-Medicine.Org | News | Comments

Medisafe 1 Technologies to Exhibit at World's Largest Medical Conference -- JERUSALEM, November 10, 2010 /-...

Ultrasound System Design Advanced With Low-Power Receiver ICs

November 10, 2010 6:03 am | Product Releases | Comments

Analog Devices Inc. has introduced two new ICs that reduce system size, complexity, and power consumption for high-end, mid-range, and portable ultrasound systems.

Advertisement

Luminex Corporation to Present at Stephens Fall Investment Conference

November 10, 2010 4:35 am | by Bio-Medicine.Org | News | Comments

AUSTIN, Texas, Nov. 10, 2010 /- Luminex Corporation (Nasdaq: LMNX ) today announced that management will present at the Stephens Fall Investment Conference to be held November 16-17, 2010, in New York. (Logo:   http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) (Logo:  ...

Hologic Encourages Health Professionals to Get the Facts About Women's Imaging at RSNA 2010

November 10, 2010 4:35 am | by Bio-Medicine.Org | News | Comments

BEDFORD, Mass., Nov. 10, 2010 /- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX ), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, will focus on products...

Cynosure to Present at 4th Annual Maxim Group Growth Conference

November 10, 2010 4:35 am | by Bio-Medicine.Org | News | Comments

WESTFORD, Mass., Nov. 10, 2010 /- Cynosure, Inc. (Nasdaq: CYNO ), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that it will present at the Maxim Group Growth Conference in New York on Thursday, November 18. The...

Dehaier Medical to Participate in MEDICA International Trade Fair

November 10, 2010 4:34 am | by Bio-Medicine.Org | News | Comments

BEIJING, Nov. 10, 2010 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM ) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it will...

New Trauma Market Research Data Covering Multiple Geographies Released by Millennium Research Group

November 10, 2010 4:33 am | by Bio-Medicine.Org | News | Comments

TORONTO, Nov. 10, 2010 /- Millennium Research Group (MRG), the global authority on medical technology market intelligence, has released its latest trauma research data for multiple geographies, including the US, Canada, Europe, Japan, Brazil, India, and China. MRG's trauma reports cover...

Advertisement

American Council on Exercise (ACE) Announces Nationwide Effort to Eliminate Obesity in America

November 10, 2010 4:33 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Nov. 10, 2010 /- The American Council on Exercise (ACE), America's leading authority on fitness and the largest nonprofit fitness certification, education and training organization in the world, today announced the launch of a national campaign that will focus on eliminating...

Quotient Clinical and Bend Research Announce Collaboration to Accelerate Advancement of New Medicines

November 10, 2010 4:33 am | by Bio-Medicine.Org | News | Comments

BEND, Ore. and NOTTINGHAM, England, Nov. 10, 2010 /- Bend Research Inc. ( www.bendres.com ), a leading independent drug-formulation development and manufacturing company, and Quotient Clinical, a business unit of Quotient Bioresearch ("Quotient," www.quotientbioresearch.com ), a leading...

PHC Announces 19.2% Increase in Fiscal 2011 First Quarter Revenues

November 10, 2010 4:33 am | by Bio-Medicine.Org | News | Comments

PEABODY, Mass., Nov. 10, 2010 /- PHC, Inc., d/b/a Pioneer Behavioral Health (NYSE Amex: PHC ), a leading provider of inpatient and outpatient behavioral health services, today reported financial results for the Company's 2011 first fiscal quarter ended September 30, 2010. First Fiscal...

Global PET SPECT Market (Positron Emission Tomography) & SPECT (Single Photon Emission Computed Tomography) to be US$ 10.3 Billion by 2015

November 10, 2010 1:36 am | by Bio-Medicine.Org | News | Comments

Global PET SPECT Market (Positron Emission Tomography) & SPECT (Single Photon Emission Computed... -- DALLAS, November 10, 2010 /PRNewswi...

Biotechs, pharma look at what's next for biosimilars

November 9, 2010 7:34 pm | by Mass High Tech: The Journal of New England Technology | News | Comments

The rubber has hit the road in the debate over legislation, approved in March, to create a regulatory pathway for generic versions of cell-based drugs known as biosimilars. The FDA has yet to issue rules on the new law, but the biotechnology world got a peek into the future landscape of...

Advertisement

2010 Prevention: National Lung Cancer Screening Trial Teleconference

November 9, 2010 12:37 pm | by AACR | News | Comments

Listen to this press conference with Christine Berg, M.D., of the Early Detection Research Group at the National Cancer Institute, who presented the initial results of the National Lung Cancer Screening Trial at AACR's Frontiers in Cancer Prevention Research Conference.

2010 Prevention: “Cancer Prevention Among Women” Teleconference

November 9, 2010 10:36 am | by AACR | News | Comments

Moderated by Judy Garber, M.D., M.P.H., president-elect of the American Association for Cancer Research and leader of the Center for Cancer Genetics and Prevention at the Dana-Farber Cancer Institute

Bradford Barton Named President, ConvaTec U.S.

November 9, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

SKILLMAN, N.J., Nov. 9, 2010 /- ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced the appointment of Bradford (Brad) Barton as President, ConvaTec U.S.   Based in Skillman, NJ, Barton will lead the...

Prevention 2010: Interview with Scott M. Lippman, M.D.

November 9, 2010 6:38 am | by AACR | News | Comments

Prevention 2010: Interview with Scott M. Lippman, M.D., chair of the department of thoracic/head and neck medical oncology at the University of Texas M D Anderson Cancer Center and editor-in-chief of one of the AACR’s journals, Cancer Prevention Research

Interview with Elizabeth H. Blackburn, Ph.D.

November 9, 2010 5:34 am | by AACR | News | Comments

Prevention 2010: Interview with Elizabeth H. Blackburn, Ph.D., AACR president, 2009 Nobel Prize in Medicine or Physiology recipient, Morris Herzstein professor of biology and physiology in the department of biochemistry and biophysics at the University of California, San Francisco.

Arcadia Resources Announces Improved Fiscal 2011 Second Quarter Results

November 9, 2010 4:36 am | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS, Nov. 9, 2010 /- Arcadia Resources, Inc. (NYSE Amex: KAD ), a leading provider of innovative consumer health care services under the Arcadia HealthCare(SM) brand, today announced fiscal 2011 second quarter net revenues of $25.8 million and a net loss of $2.9 million, or $0.02...

PAREXEL International to Participate in the Lazard Capital Markets Healthcare Conference in New York and the Jefferies Healthcare Summit in Boston

November 9, 2010 1:36 am | by Bio-Medicine.Org | News | Comments

BOSTON, Nov. 9, 2010 /- PAREXEL International Corporation (Nasdaq: PRXL ) announced today it will be presenting at the Lazard Capital Markets Healthcare Conference in New York.  Josef von Rickenbach, Chairman and Chief Executive Officer will be making a presentation on PAREXEL at...

China BCT Reschedules Conference Call to Discuss Third Quarter 2010 Results

November 9, 2010 1:35 am | by Bio-Medicine.Org | News | Comments

China BCT Reschedules Conference Call to Discuss Third Quarter 2010... -- LIUZHOU CITY, Guangxi, China, Nov. 9, 2010 /PRNewswire-Asia-FirstCall/ --

Arena Pharmaceuticals Announces Third Quarter 2010 Financial Results and Reviews Recent Developments

November 8, 2010 10:34 pm | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Nov. 9, 2010 /- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) today reported financial results for the third quarter ended September 30, 2010. Arena also reported earlier today top-line results from its lorcaserin Phase 3 BLOOM-DM (Behavioral modification and Lorcaserin for...

Intercell AG Announces Q3 2010 Results and Updates on R & D Progress and Management

November 8, 2010 10:33 pm | by Bio-Medicine.Org | News | Comments

VIENNA, Nov. 9, 2010 /- Today, Intercell AG (VSE: ICLL) announced its financial results for the third quarter of 2010 and presented an update on the Company's key R&D programs as well as changes to the Management Board. Financial Results IXIARO and JESPECT sales revenues continue...

Prevention 2010: Interview with Curtis C. Harris, M.D

November 8, 2010 1:38 pm | by AACR | News | Comments

Dr. Harris discusses the topic of his distinguished lecture, inflammation and cancer and the role of infection and chronic inflammation in cancer development.

2010 Prevention: Chemoprevention Teleconference Recording

November 8, 2010 1:38 pm | by AACR | News | Comments

Moderated by Scott Lippman, M.D., editor-in-chief of Cancer Prevention Research and professor and chair in the department of thoracic head and neck medical oncology at The University of Texas MD Anderson Cancer Center

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading